1) What is the business overview of Standard Glass Lining?
Standard Glass Lining is one of the top five specialty engineering equipment manufacturers for the pharmaceutical and chemical sectors in India, in terms of revenue in FY24, with in-house capabilities across the value chain. Its capabilities include design, engineering, manufacturing, assembly, installation and commissioning solutions as well as establishment of standard operating procedures on a turnkey basis for pharmaceutical and chemical manufacturers.
2) What is the industry overview of Standard Glass Lining?
The glass-lined equipment (GLE) industry is poised for significant growth driven by multiple factors. GLE protects the contained media from exposure to water, other chemicals, salts and corrosion, providing a desirable environment for storing the media. GLE is resistant to contamination and able to function in various environments.
3) What is the current GMP of standard glass lining?
According to market analysts, the current GMP of standard glass lining is Rs. 97, indicating a premium of 69% for the issue.
4) What is the size of Standard Glass Lining IPO?
The IPO raised Rs. 210 crore is a mix of fresh equity issue and promoter selling and offer for sale of 1,42,89,367 equity shares by the promoter group and other selling shareholders.
5) What is the price band for Standard Glass Lining IPO?
The company paid Rs. 133-140 price band, where investors can bid for 107 shares in one lot.
Also Read: IPO Calendar: 2025 starts on a strong note with 7 new issues and 6 listings
6) What is the structure of Standard Glass Lining IPO?
About 50% of the public offering is reserved for qualified institutional buyers, 35% for retail investors and the remaining 15% for non-institutional investors.
7) How is the financial performance of Standard Glass Lining?
In FY24, the company’s revenue from operations grew 9% year-on-year to Rs. 544 crore, while profit after tax increased by 13% to Rs. 60 crores. For the six months ended September 2024, revenue was Rs. 307 crore and a profit of Rs. was 36 crores.
8) What are the objectives of IPO of Sai Life Sciences?
The proceeds from its fresh issue will be used to fund capital expenditure requirements for the company’s purchase of machinery and equipment, repayment of debt, investment in its wholly-owned materials subsidiary S2 Engineering Industries.
Funding inorganic growth through strategic investments and general corporate objectives.
9) Who is the Book Running Lead Manager for Sai Life Sciences IPO?
IIFL Capital Services and Motilal Oswal Investment Advisors are the book-running lead managers, and KFin Technologies is the registrar of the issue.
10) When is the share allotment and listing date of Sai Life Sciences IPO?
The allotment of shares for the IPO will be finalized on January 9 and the company is expected to be listed on the stock exchange on January 13.
(You can now subscribe to our ETMarkets WhatsApp channel)